Correlation Between Tectonic Therapeutic, and Karyopharm Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tectonic Therapeutic, and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tectonic Therapeutic, and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tectonic Therapeutic, and Karyopharm Therapeutics, you can compare the effects of market volatilities on Tectonic Therapeutic, and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tectonic Therapeutic, with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tectonic Therapeutic, and Karyopharm Therapeutics.

Diversification Opportunities for Tectonic Therapeutic, and Karyopharm Therapeutics

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Tectonic and Karyopharm is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Tectonic Therapeutic, and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Tectonic Therapeutic, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tectonic Therapeutic, are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Tectonic Therapeutic, i.e., Tectonic Therapeutic, and Karyopharm Therapeutics go up and down completely randomly.

Pair Corralation between Tectonic Therapeutic, and Karyopharm Therapeutics

Given the investment horizon of 90 days Tectonic Therapeutic, is expected to generate 1.75 times more return on investment than Karyopharm Therapeutics. However, Tectonic Therapeutic, is 1.75 times more volatile than Karyopharm Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Karyopharm Therapeutics is currently generating about -0.71 per unit of risk. If you would invest  4,804  in Tectonic Therapeutic, on September 26, 2024 and sell it today you would earn a total of  252.00  from holding Tectonic Therapeutic, or generate 5.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tectonic Therapeutic,  vs.  Karyopharm Therapeutics

 Performance 
       Timeline  
Tectonic Therapeutic, 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tectonic Therapeutic, are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Tectonic Therapeutic, showed solid returns over the last few months and may actually be approaching a breakup point.
Karyopharm Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Karyopharm Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Tectonic Therapeutic, and Karyopharm Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tectonic Therapeutic, and Karyopharm Therapeutics

The main advantage of trading using opposite Tectonic Therapeutic, and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tectonic Therapeutic, position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.
The idea behind Tectonic Therapeutic, and Karyopharm Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital